RA
AZN icon

RFG Advisory’s AstraZeneca AZN Stock Holding History

RFG Advisory’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$235K Sell
1,237
-1,987
-62% -$374K ﹤0.01% 1026
2026
Q1 		$636K Sell
3,224
-4,129
-56% -$796K 0.01% 665
2025
Q4 		$1.35M Buy
+7,353
New +$1.29M 0.03% 443

Other funds holding AZN

RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
CDDEC
Caisse Des Depots Et Consignations Paris, France $5.91B AUM 35.65% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
BTCPP
Border to Coast Pensions Partnership Leeds, United Kingdom $6.78B AUM 31.6% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
AV
ASR Vermogensbeheer Utrecht, Netherlands $9.71B AUM 37.32% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

RFG Advisory's AZN Position: Q2 2026 in Review

RFG Advisory reduced its AstraZeneca (AZN) stake by 62% in Q2 2026, selling an estimated $374K and leaving 1,237 shares worth $235K. The position accounts for ﹤0.01% of the portfolio, ranked #1026.

RFG Advisory first reported a position in AZN in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.35M in Q4 2025. 532 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • RFG Advisory held 1,237 shares of AstraZeneca worth $235K as of Q2 2026.
  • RFG Advisory sold 1,987 AstraZeneca shares in Q2 2026, an estimated $374K.
  • AstraZeneca made up ﹤0.01% of RFG Advisory's portfolio in Q2 2026, its #1026 holding.
  • RFG Advisory first reported a position in AstraZeneca in Q4 2025 and has held it in 3 quarters since.
  • RFG Advisory's AstraZeneca position peaked at $1.35M in Q4 2025.
  • 532 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on RFG Advisory's 13F filing for Q2 2026, filed 15 Jul 2026.